Proteasome Inhibition Is Partially Effective in Attenuating Pre-Existing Immunity against Recombinant Adeno-Associated Viral Vectors

Open Access

Peer-reviewed

Research Article

Jozsef Karman ,

* E-mail: jozsef.karman@genzyme.com

Affiliation Genetic Disease Science, Genzyme Corporation, Framingham, Massachusetts, United States of America
⨯
Nathan K. Gumlaw,

Affiliation Genetic Disease Science, Genzyme Corporation, Framingham, Massachusetts, United States of America
⨯
Jinhua Zhang,

Affiliation Genetic Disease Science, Genzyme Corporation, Framingham, Massachusetts, United States of America
⨯
Ji-Lei Jiang,

Affiliation Genetic Disease Science, Genzyme Corporation, Framingham, Massachusetts, United States of America
⨯
Seng H. Cheng,

Affiliation Genetic Disease Science, Genzyme Corporation, Framingham, Massachusetts, United States of America
⨯
Yunxiang Zhu

Affiliation Genetic Disease Science, Genzyme Corporation, Framingham, Massachusetts, United States of America
⨯

Reader Comments (0)

Antibodies
Is the Subject Area "Antibodies" applicable to this article?

Thanks for your feedback.
B cells
Is the Subject Area "B cells" applicable to this article?

Thanks for your feedback.
T cells
Is the Subject Area "T cells" applicable to this article?

Thanks for your feedback.
Plasma cells
Is the Subject Area "Plasma cells" applicable to this article?

Thanks for your feedback.
Cytotoxic T cells
Is the Subject Area "Cytotoxic T cells" applicable to this article?

Thanks for your feedback.
Enzyme-linked immunoassays
Is the Subject Area "Enzyme-linked immunoassays" applicable to this article?

Thanks for your feedback.
Memory B cells
Is the Subject Area "Memory B cells" applicable to this article?

Thanks for your feedback.
Immune response
Is the Subject Area "Immune response" applicable to this article?

Thanks for your feedback.